ERα + Brpkp110 tumors also had significantly decreased numbers of type 1 and type 2 conventional dendritic cells (cDC1 and cDC2) suggesting a weakened capacity for T cell priming considered critical for anti-tumor immunity (Fig. 1C). This evidence concerns the gene ESR1 and neoplasm.